212 related articles for article (PubMed ID: 33120753)
1. Hypofibrinogenemia induced by high-dose tigecycline-case report and review of literature.
Fan Q; Huang W; Weng Y; Xie X; Shi Z
Medicine (Baltimore); 2020 Oct; 99(43):e22638. PubMed ID: 33120753
[TBL] [Abstract][Full Text] [Related]
2. A case report of patient with severe acute cholangitis with tigecycline treatment causing coagulopathy and hypofibrinogenemia.
Wu X; Zhao P; Dong L; Zhang X
Medicine (Baltimore); 2017 Dec; 96(49):e9124. PubMed ID: 29245350
[TBL] [Abstract][Full Text] [Related]
3. Tigecycline-associated hypofibrinogenemia in a real-world setting.
Campany-Herrero D; Larrosa-Garcia M; Lalueza-Broto P; Rivera-Sánchez L; Espinosa-Pereiro J; Mestre-Torres J; Pigrau-Serrallach C
Int J Clin Pharm; 2020 Aug; 42(4):1184-1189. PubMed ID: 32504166
[TBL] [Abstract][Full Text] [Related]
4. Analysis of the clinical characteristics of tigecycline-induced hypofibrinogenemia.
Lei H; Liu X; Li Z; Wang C
J Chemother; 2023 Jul; 35(4):292-297. PubMed ID: 35904191
[TBL] [Abstract][Full Text] [Related]
5. Acute pancreatitis caused by tigecycline and furosemide combination treatment and hypofibrinogenemia caused by tigecycline: A case report.
Li ZK; Zheng P
Int J Clin Pharmacol Ther; 2023 Oct; 61(10):466-470. PubMed ID: 37548456
[TBL] [Abstract][Full Text] [Related]
6. Risk factors for tigecycline-induced hypofibrinogenaemia.
Zhang Q; Wang J; Liu H; Ma W; Zhou S; Zhou J
J Clin Pharm Ther; 2020 Dec; 45(6):1434-1441. PubMed ID: 32860258
[TBL] [Abstract][Full Text] [Related]
7. Safety of Tigecycline in Patients on Antithrombotic Therapy: A Single-Center Retrospective Study.
Lin C; Tan M; Wang D; Gu C; Wu Y; Wang S
Pharmacology; 2023; 108(6):540-549. PubMed ID: 37751720
[TBL] [Abstract][Full Text] [Related]
8. Clinical characteristics and risk factors of tigecycline-associated hypofibrinogenaemia in critically ill patients.
Hu J; Xiao YH; Zheng Y; Lai YX; Fang XL; Fang Q
Eur J Clin Pharmacol; 2020 Jul; 76(7):913-922. PubMed ID: 32355990
[TBL] [Abstract][Full Text] [Related]
9. Rare severe hypofibrinogenemia induced by tissue plasminogen activator in stroke patients: Case report.
Huang X; Cao L
Medicine (Baltimore); 2021 Mar; 100(9):e24978. PubMed ID: 33655967
[TBL] [Abstract][Full Text] [Related]
10. Tigecycline-induced life-threatening coagulopathy in a patient with a Mycobacterium abscess: a case report and step-by-step diagnostic approach.
Akalay S; Vanassche T; De Munter P
Acta Clin Belg; 2021 Oct; 76(5):410-414. PubMed ID: 32255411
[TBL] [Abstract][Full Text] [Related]
11. Serum concentration as a predictor of tigecycline-induced hypofibrinogenemia in critically ill patients: A retrospective cohort study.
Yang X; Jin L; Luo X; Wang M; Zhu H; Zhou Y; Ge W
Int J Infect Dis; 2022 Oct; 123():136-142. PubMed ID: 36028209
[TBL] [Abstract][Full Text] [Related]
12. Tigecycline-induced coagulopathy: a literature review.
Cui N; Cai H; Li Z; Lu Y; Wang G; Lu A
Int J Clin Pharm; 2019 Dec; 41(6):1408-1413. PubMed ID: 31713108
[TBL] [Abstract][Full Text] [Related]
13. Incidence, characteristics and risk factors of hypofibrinogenemia associated with tigecycline: A multicenter retrospective study in China.
Leng B; Shen C; Gao T; Zhao K; Zhao X; Guo Y; Wu J; Yang J; Fang W; Zhang J; Zhang Y; Sun C; Duan L; Huang J; Qi Y; Yan G
Front Pharmacol; 2022; 13():943674. PubMed ID: 36304151
[No Abstract] [Full Text] [Related]
14. Hypofibrinogenemia induced by tigecycline: a potentially life-threatening coagulation disorder.
Sabanis N; Paschou E; Gavriilaki E; Kalaitzoglou A; Vasileiou S
Infect Dis (Lond); 2015; 47(10):743-6. PubMed ID: 25951751
[TBL] [Abstract][Full Text] [Related]
15. Risk Factors for Tigecycline-Associated Hypofibrinogenemia.
Liu J; Yan Y; Zhang F
Ther Clin Risk Manag; 2021; 17():325-332. PubMed ID: 33888987
[TBL] [Abstract][Full Text] [Related]
16. Severe coagulation disorder with hypofibrinogenemia associated with the use of tigecycline.
Pieringer H; Schmekal B; Biesenbach G; Pohanka E
Ann Hematol; 2010 Oct; 89(10):1063-4. PubMed ID: 20174923
[No Abstract] [Full Text] [Related]
17. Tigecycline-associated hypofibrinogenemia: A case report and review of the literature.
Wu PC; Wu CC
IDCases; 2018; 11():56-57. PubMed ID: 29560313
[TBL] [Abstract][Full Text] [Related]
18. Life-threatening coagulopathy and hypofibrinogenaemia induced by tigecycline in a patient with advanced liver cirrhosis.
Rossitto G; Piano S; Rosi S; Simioni P; Angeli P
Eur J Gastroenterol Hepatol; 2014 Jun; 26(6):681-4. PubMed ID: 24667348
[TBL] [Abstract][Full Text] [Related]
19. Risk factors of tigecycline-associated fibrinogen reduction in patients with renal transplantation: a case-control study.
Xie W; Ma K; Xu Z; Xie J; Lu X; Wang X
Transl Androl Urol; 2022 Oct; 11(10):1410-1418. PubMed ID: 36386261
[TBL] [Abstract][Full Text] [Related]
20. Acute liver failure caused by high-dose tigecycline: A case report.
Zhang Y; Wang J; Tan Y; Wu J
Int J Clin Pharmacol Ther; 2024 Jul; 62(7):339-344. PubMed ID: 38606856
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
